Introduction 

Atrial fibrillation (AFib) is a common arrhythmia that becomes more complex when coupled with heart enlargement, or cardiomegaly.¹ Heart enlargement, known as cardiomegaly, is often a sign of underlying cardiovascular disease and can contribute to an increased risk of stroke, heart failure, and other complications associated with AFib.² Managing AFib in this context requires a multifaceted approach that combines lifestyle changes, medications, procedural interventions, and regular monitoring.

This article explores approaches to treating AFib in patients with heart enlargement aiming to manage symptoms, maintain stable heart rhythms, reduce risks, and ultimately improve quality of life.

The intersection between AFib and heart enlargement

AFib occurs when the heart's upper chambers (the atria) beat irregularly and out of sync with the lower chambers (the ventricles). This leads to inefficient blood flow, increasing the risk of blood clots and stroke.¹ Heart enlargement, on the other hand, can result from high blood pressure, heart valve disease, or conditions like heart failure.² When these two conditions coexist, they can exacerbate each other, creating a cycle that complicates treatment efforts. Enlarged hearts are often less responsive to traditional AFib treatments, and the risk of developing heart failure or experiencing a stroke is heightened.

The treatment of AFib in the context of an enlarged heart needs to be tailored to address both the arrhythmia and the underlying causes of cardiomegaly. Successful management involves stabilizing heart rhythms, reducing the heart’s workload, and managing associated risk factors such as hypertension and obesity.³

Initial assessment

Medical history and physical examination

The treatment process begins with a thorough medical history and physical examination. This includes understanding the frequency and duration of AFib episodes, assessing potential triggers, and evaluating symptoms such as palpitations, chest pain, or shortness of breath.

Diagnostic Testing

To confirm AFib and assess heart enlargement, several diagnostic tools are required:

• Echocardiography: A non-invasive test that uses ultrasound waves to visualize the heart’s structure and function. It allows clinicians to measure the degree of enlargement and identify any structural abnormalities²
• Electrocardiogram (ECG): This test records the electrical activity of the heart to confirm AFib and assess its severity²
• Blood Tests: Tests for thyroid function, electrolyte levels, and markers of heart failure can reveal underlying health issues that may affect the treatment plan²
• Cardiac MRI: In certain cases, a cardiac MRI may provide a detailed view of the heart's size, wall thickness, and any areas of scarring or fibrosis²

Lifestyle modifications for AFib and heart health

Lifestyle modifications form the foundation of AFib and heart enlargement management. While they do not replace medical treatments, they support heart health, reduce risk factors, and can improve treatment outcomes.

• Weight management: Weight loss can help control AFib symptoms and reduce the burden on an enlarged heart. Patients are encouraged to achieve a healthy body mass index (BMI) through diet and exercise⁴
• Dietary changes: A heart-healthy diet such as the DASH or Mediterranean diet can help reduce blood pressure and cholesterol levels, which are critical in managing cardiomegaly.⁴ These diets emphasize fruits, vegetables, whole grains, and lean proteins, while limiting salt, sugar, and unhealthy fats
• Physical activity: Regular, moderate-intensity exercise has been shown to support heart health. However, overexertion can aggravate AFib, so patients should work closely with their healthcare providers to find an appropriate exercise regimen⁴
• Alcohol and caffeine limitation: Alcohol and caffeine can act as triggers for AFib episodes, especially in those with an enlarged heart. Reducing or eliminating these substances is often advised⁴
• Sleep apnea screening and treatment: Sleep apnea is common in patients with both AFib and heart enlargement. Treating sleep apnea, often with a CPAP machine, can improve symptoms and reduce AFib recurrence⁴

Pharmacological management

Rate Control

Managing heart rate is crucial for AFib patients, especially those with heart enlargement. Rate control medications help prevent the heart from beating too quickly, which can exacerbate symptoms and further stress the enlarged heart.

• Beta blockers:

Medications such as metoprolol are commonly prescribed to slow the heart rate, which helps improve blood flow and reduce symptoms.⁵

• Calcium channel blockers:

Drugs like diltiazem can also help control heart rate and are an alternative for those who may not tolerate beta-blockers.⁵

• Digoxin:

In cases where other drugs are not effective, digoxin may be considered, though careful monitoring is required to avoid toxicity.⁵

Rhythm Control

For some patients, especially those with persistent or symptomatic AFib, restoring and maintaining a normal heart rhythm may be preferable.

• Antiarrhythmic Medications:

Amiodarone and dronedarone are common choices for rhythm control. Amiodarone is often used for patients with structural heart disease, while dronedarone may be an option for patients without severe heart failure.⁵

• Catheter Ablation:

In patients who do not respond to medications or have recurrent symptoms, catheter ablation may be considered.⁵ This procedure involves isolating the areas of heart tissue responsible for AFib. However, it may be less effective in patients with significant heart enlargement, as structural changes can make it difficult to achieve successful ablation.

Anticoagulation therapy

One of the primary risks associated with AFib is stroke. Anticoagulation therapy is crucial for stroke prevention in AFib patients, especially in those with an enlarged heart.

• Direct Oral Anticoagulants (DOACs):

DOACs like apixaban and rivaroxaban are preferred for most patients as they do not require regular monitoring and have a favorable safety profile.⁶

• Warfarin:

For patients who have significant renal impairment or are not suited to DOACs, warfarin may be prescribed, though it requires regular INR monitoring.⁶

• Left Atrial Appendage Occlusion:

For patients with a high bleeding risk or contraindications to anticoagulation, a left atrial appendage occlusion device may be an option. This procedure can help reduce stroke risk in patients unable to take blood thinners.⁶

Non-pharmacological Interventions

In cases where medication alone is insufficient, non-pharmacological treatments may provide additional symptom relief.⁷

Electrocardioversion 

This is a procedure where an electrical shock is delivered to reset the heart’s rhythm. It is particularly useful for patients with acute, symptomatic AFib. Before the procedure, anticoagulation or imaging (e.g., transesophageal echocardiography) is required to ensure no blood clots are present.⁷

Catheter Ablation

Ablation involves targeting the tissue that causes AFib. It may be effective in patients with smaller heart enlargement but tends to be less effective in advanced cardiomegaly due to scar tissue and structural changes.⁷

Heart failure management

For patients with heart enlargement who also exhibit symptoms of heart failure, additional treatments may be required.⁸

• ACE Inhibitors or ARBs: These medications reduce blood pressure and help slow heart remodeling, which can relieve stress on the heart muscle and improve function⁸
• Beta-Blockers: In addition to rate control, beta-blockers may help slow the progression of heart failure⁸
• Diuretics: For patients with fluid retention, diuretics can help alleviate symptoms by reducing fluid buildup⁹
• Aldosterone antagonists: These medications may be beneficial for patients with heart failure with reduced ejection fraction, helping to control fluid retention and prevent heart remodeling⁸

Monitoring and follow-Up

Ongoing monitoring and regular follow-up appointments are essential for managing both AFib and heart enlargement.

• Clinic Visits: Routine visits help track treatment progress, adjust medications, and address any emerging issues
• Holter Monitoring: Periodic Holter monitoring assesses the effectiveness of rhythm and rate control
• Anticoagulation Monitoring: For patients on warfarin, regular INR checks are needed to ensure blood-thinning levels remain safe and effective
• Lifestyle Support: Ongoing encouragement to maintain a healthy diet, exercise, and avoid triggers is essential for long-term success

Patient education and support

Educating patients on recognizing AFib symptoms, understanding their medications, and knowing when to seek emergency help is a key component of the treatment plan¹⁰. Patients should be aware of the signs of stroke, worsening heart failure, and AFib recurrence, and have a clear plan for managing these events¹⁰.

Conclusion

Managing AFib in patients with heart enlargement requires a multi-pronged strategy that addresses both rhythm control and the underlying causes of cardiomegaly. By combining lifestyle changes, medications, procedural interventions, and vigilant monitoring, clinicians can provide effective and individualized care that improves patients’ quality of life and reduces the risk of complications.